APO RESEARCH · REPORT
Hemoperfusion Production
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
Product & engineering
Understand the product.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
Selected research
Market Structure
Global Hemoperfusion Production Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent.
Read the full market overview
In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.
This report provides an overview of the global Hemoperfusion Production market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hemoperfusion Production and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hemoperfusion Production sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemoperfusion Production market size, projected growth trends, production technologies, key applications, and end-use industries.
Hemoperfusion Production Segment by Company
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents
Hemoperfusion Production Segment by Type
Resin Adsorption
Activated Carbon Adsorption
Others
Hemoperfusion Production Segment by Application
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
Hemoperfusion Production Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoperfusion Production market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemoperfusion Production and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoperfusion Production.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hemoperfusion Production market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemoperfusion Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemoperfusion Production in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hemoperfusion Production in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Resin Adsorption
- Activated Carbon Adsorption
- Others
Applications
- Overdose
- Specific Intoxications
- Certain Autoimmune Diseases
- Hepatic Encephalopathy
- Others
Companies covered
- Jafron Biomedical
- Baxter (Gambro)
- Biosun Medical
- Toray Medical
- Asahi-Kasei
- Kaneka
- Zibo Kangbei
- Aier
- Cytosorbents
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hemoperfusion Production Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hemoperfusion Production Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Hemoperfusion Production Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Hemoperfusion Production Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Hemoperfusion Production Market Dynamics
- 2.1 Hemoperfusion Production Industry Trends
- 2.2 Hemoperfusion Production Industry Drivers
- 2.3 Hemoperfusion Production Industry Opportunities and Challenges
- 2.4 Hemoperfusion Production Industry Restraints
3 Hemoperfusion Production Market by Manufacturers
- 3.1 Global Hemoperfusion Production Revenue by Manufacturers (2021-2026)
- 3.2 Global Hemoperfusion Production Sales by Manufacturers (2021-2026)
- 3.3 Global Hemoperfusion Production Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Hemoperfusion Production Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hemoperfusion Production Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hemoperfusion Production Manufacturers, Product Type & Application
- 3.7 Global Hemoperfusion Production Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hemoperfusion Production Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hemoperfusion Production Players Market Share by Revenue in 2025
- 3.8.3 2025 Hemoperfusion Production Tier 1, Tier 2, and Tier 3
4 Hemoperfusion Production Market by Type
- 4.1 Hemoperfusion Production Type Introduction
- 4.1.1 Resin Adsorption
- 4.1.2 Activated Carbon Adsorption
- 4.1.3 Others
- 4.2 Global Hemoperfusion Production Sales by Type
- 4.2.1 Global Hemoperfusion Production Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hemoperfusion Production Sales by Type (2021-2032)
- 4.2.3 Global Hemoperfusion Production Sales Market Share by Type (2021-2032)
- 4.3 Global Hemoperfusion Production Revenue by Type
- 4.3.1 Global Hemoperfusion Production Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hemoperfusion Production Revenue by Type (2021-2032)
- 4.3.3 Global Hemoperfusion Production Revenue Market Share by Type (2021-2032)
5 Hemoperfusion Production Market by Application
- 5.1 Hemoperfusion Production Application Introduction
- 5.1.1 Overdose
- 5.1.2 Specific Intoxications
- 5.1.3 Certain Autoimmune Diseases
- 5.1.4 Hepatic Encephalopathy
- 5.1.5 Others
- 5.2 Global Hemoperfusion Production Sales by Application
- 5.2.1 Global Hemoperfusion Production Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hemoperfusion Production Sales by Application (2021-2032)
- 5.2.3 Global Hemoperfusion Production Sales Market Share by Application (2021-2032)
- 5.3 Global Hemoperfusion Production Revenue by Application
- 5.3.1 Global Hemoperfusion Production Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hemoperfusion Production Revenue by Application (2021-2032)
- 5.3.3 Global Hemoperfusion Production Revenue Market Share by Application (2021-2032)
6 Global Hemoperfusion Production Sales by Region
- 6.1 Global Hemoperfusion Production Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hemoperfusion Production Sales by Region (2021-2032)
- 6.2.1 Global Hemoperfusion Production Sales by Region (2021-2026)
- 6.2.2 Global Hemoperfusion Production Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hemoperfusion Production Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Hemoperfusion Production Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hemoperfusion Production Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Hemoperfusion Production Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hemoperfusion Production Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Hemoperfusion Production Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Hemoperfusion Production Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Hemoperfusion Production Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Hemoperfusion Production Revenue by Region
- 7.1 Global Hemoperfusion Production Revenue by Region
- 7.1.1 Global Hemoperfusion Production Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Hemoperfusion Production Revenue by Region (2021-2026)
- 7.1.3 Global Hemoperfusion Production Revenue by Region (2027-2032)
- 7.1.4 Global Hemoperfusion Production Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Hemoperfusion Production Revenue (2021-2032)
- 7.2.2 North America Hemoperfusion Production Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Hemoperfusion Production Revenue (2021-2032)
- 7.3.2 Europe Hemoperfusion Production Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Hemoperfusion Production Revenue (2021-2032)
- 7.4.2 Asia-Pacific Hemoperfusion Production Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Hemoperfusion Production Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Hemoperfusion Production Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Jafron Biomedical
- 8.1.1 Jafron Biomedical Company Information
- 8.1.2 Jafron Biomedical Business Overview
- 8.1.3 Jafron Biomedical Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Jafron Biomedical Hemoperfusion Production Product Portfolio
- 8.1.5 Jafron Biomedical Recent Developments
- 8.2 Baxter (Gambro)
- 8.2.1 Baxter (Gambro) Company Information
- 8.2.2 Baxter (Gambro) Business Overview
- 8.2.3 Baxter (Gambro) Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Baxter (Gambro) Hemoperfusion Production Product Portfolio
- 8.2.5 Baxter (Gambro) Recent Developments
- 8.3 Biosun Medical
- 8.3.1 Biosun Medical Company Information
- 8.3.2 Biosun Medical Business Overview
- 8.3.3 Biosun Medical Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Biosun Medical Hemoperfusion Production Product Portfolio
- 8.3.5 Biosun Medical Recent Developments
- 8.4 Toray Medical
- 8.4.1 Toray Medical Company Information
- 8.4.2 Toray Medical Business Overview
- 8.4.3 Toray Medical Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Toray Medical Hemoperfusion Production Product Portfolio
- 8.4.5 Toray Medical Recent Developments
- 8.5 Asahi-Kasei
- 8.5.1 Asahi-Kasei Company Information
- 8.5.2 Asahi-Kasei Business Overview
- 8.5.3 Asahi-Kasei Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Asahi-Kasei Hemoperfusion Production Product Portfolio
- 8.5.5 Asahi-Kasei Recent Developments
- 8.6 Kaneka
- 8.6.1 Kaneka Company Information
- 8.6.2 Kaneka Business Overview
- 8.6.3 Kaneka Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Kaneka Hemoperfusion Production Product Portfolio
- 8.6.5 Kaneka Recent Developments
- 8.7 Zibo Kangbei
- 8.7.1 Zibo Kangbei Company Information
- 8.7.2 Zibo Kangbei Business Overview
- 8.7.3 Zibo Kangbei Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Zibo Kangbei Hemoperfusion Production Product Portfolio
- 8.7.5 Zibo Kangbei Recent Developments
- 8.8 Aier
- 8.8.1 Aier Company Information
- 8.8.2 Aier Business Overview
- 8.8.3 Aier Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Aier Hemoperfusion Production Product Portfolio
- 8.8.5 Aier Recent Developments
- 8.9 Cytosorbents
- 8.9.1 Cytosorbents Company Information
- 8.9.2 Cytosorbents Business Overview
- 8.9.3 Cytosorbents Hemoperfusion Production Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cytosorbents Hemoperfusion Production Product Portfolio
- 8.9.5 Cytosorbents Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Hemoperfusion Production Value Chain Analysis
- 9.1.1 Hemoperfusion Production Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hemoperfusion Production Production Mode & Process
- 9.2 Hemoperfusion Production Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hemoperfusion Production Distributors
- 9.2.3 Hemoperfusion Production Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst